Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biogen Inc | 33.1B | 26.4x | -18.14% |
Biontech SE | 20.1B | 166.6x | --- |
Charles River Laboratories International Inc | 11.4B | 27.4x | +15.57% |
Genmab A/S | 18.5B | 23.6x | +22.71% |
Grifols SA | 6.2B | 25.4x | --- |
Halozyme Therapeutics Inc | 7.1B | 23.3x | --- |
ICON PLC | 25.9B | 39.2x | +4.68% |
Incyte Corp | 15.4B | 20.8x | +39.11% |
IQVIA Holdings Inc | 42.3B | 31.1x | +46.62% |
Medpace Holdings Inc | 11.8B | 35.9x | +35.10% |
Regeneron Pharmaceuticals Inc | 117.3B | 31.9x | +10.93% |
Vertex Pharmaceuticals Inc | 127.0B | 32.1x | +46.35% |
Affymax Inc | 26.2K | 0.0x | --- |
Alkermes Plc | 4.6B | 10.4x | --- |
Bio-Techne Corp | 12.4B | 64.1x | +23.61% |
Biomarin Pharmaceutical Inc | 16.3B | 79.0x | --- |
Cannabis Bioscience International Holdings Inc | 9.3M | 0.0x | --- |
Catalyst Pharmaceuticals Inc | 2.1B | 32.7x | --- |
CervoMed Inc | 118.6M | 7.1x | --- |
CytomX Therapeutics Inc | 110.6M | 7.6x | --- |
Dynavax Technologies Corp | 1.5B | 232.4x | --- |
Entrada Therapeutics Inc | 632.2M | 27.5x | --- |
Enzon Pharmaceuticals Inc | 11.1M | 50.3x | -60.21% |
Exelixis Inc | 6.7B | 36.2x | -21.77% |
Fennec Pharmaceuticals Inc | 180.6M | 178.0x | --- |
Galapagos NV | 1.8B | 54.4x | --- |
Halberd Corp | 4.5M | 3.1x | --- |
Kamada Ltd | 341.4M | 23.2x | -22.48% |
Krystal Biotech Inc | 6.0B | 113.5x | --- |
LadRx Corp | 1.2M | 0.7x | --- |
MannKind Corp | 1.6B | 249.7x | --- |
MEI Pharma Inc | 23.1M | 0.9x | --- |
MiMedx Group Inc | 1.1B | 20.6x | --- |
Neurocrine Biosciences Inc | 14.7B | 40.3x | +62.04% |
Oramed Pharmaceuticals Inc | 103.2M | 10.5x | --- |
Organogenesis Holdings Inc | 426.9M | 74.5x | --- |
Protagonist Therapeutics Inc | 2.4B | 16.4x | --- |
Protalix Biotherapeutics Inc | 84.3M | 19.1x | --- |
Puma Biotechnology Inc | 190.1M | 11.9x | --- |
Qiagen NV | 9.4B | 29.2x | +12.66% |
Redhill Biopharma Ltd | 12.1M | 0.1x | --- |
Sarepta Therapeutics Inc | 13.9B | 1,810.5x | --- |
Spero Therapeutics Inc | 76.4M | 3.4x | --- |
Tectonic Therapeutic Inc | 250.5M | 2.1x | --- |
TG Therapeutics Inc | 3.1B | 93.3x | --- |
TRACON Pharmaceuticals Inc | 1.8M | 1.0x | --- |
United Therapeutics Corp | 14.9B | 16.0x | +8.22% |
Vericel Corp | 2.5B | 5,472.8x | --- |
Viaderma Inc | 4.0M | 0.0x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
Company | Dividend Yield |
---|---|
BIO-TECHNE Corp | 0.41% |
Avid Bioservices Inc | --- |
XOMA Royalty Corp | --- |
Alkermes Plc | --- |
Ionis Pharmaceuticals Inc | --- |